Gastric Cancer: TEVIMBRA Approved in U.S. for First-Line Treatment
Gastric Cancer: TEVIMBRA Approved in U.S. for First-Line Treatment BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company set to change its name to BeOne Medicines Ltd., today announced that the U.S. Food and Drug Administration (FDA)…
Takeda Announces HYQVIA® 10% Injection Approval in Japan for Agammaglobulinemia
Takeda Announces HYQVIA® 10% Injection Approval in Japan for Agammaglobulinemia Takeda (TSE:4502/NYSE:TAK) has announced that the Japanese Ministry of Health, Labour and Welfare has approved HYQVIA® [Immune Globulin Infusion 10% (Human) with Recombinant Human Hyaluronidase] for the treatment of patients…
Kerecis Expands Silicone Fish-Skin Line with SurgiClose®
Kerecis Expands Silicone Fish-Skin Line with SurgiClose® Kerecis, a leader in the use of sustainably sourced fish skin and fatty acids for cellular therapy, tissue regeneration, and protection, has announced the launch of SurgiClose® Silicone. This innovative product combines fish-skin…
Wearables to Be Used by 50% of Older Adults for Life-Saving Alerts by 2034, Predicts ScienceSoft
Wearables to Be Used by 50% of Older Adults for Life-Saving Alerts by 2034, Predicts ScienceSoft ScienceSoft has released a comprehensive report examining the future of wearables in preventive healthcare for older adults. The study, supported by data from statistical…
Tivic Health CEO’s Letter to Shareholders
Tivic Health CEO’s Letter to Shareholders Tivic Health® Systems, Inc. (Nasdaq: TIVC), a health tech company pioneering bioelectronic medicine, has released its annual letter from the CEO to shareholders, highlighting key milestones in 2024 and setting the stage for exciting…
Sensorion Completes Enrollment of First Cohort in Audiogene Phase 1/2 Trial
Sensorion Completes Enrollment of First Cohort in Audiogene Phase 1/2 Trial Sensorion (FR0012596468 – ALSEN), a pioneering clinical-stage biotechnology company focused on developing innovative therapies for hearing loss disorders, has successfully completed patient enrollment for the first cohort in its…
Digital Health Tools Expanding to Support Patient Care, Reports IQVIA
Digital Health Tools Expanding to Support Patient Care, Reports IQVIA Despite a decline in venture funding for digital health companies over the past two and a half years, digital health products and solutions are rapidly evolving to enhance patient diagnosis,…
Investor Consortium and NEA to Take NeueHealth Private
Investor Consortium and NEA to Take NeueHealth Private Investor Consortium, led by New Enterprise Associates (NEA), has announced that it has entered into a definitive merger agreement to acquire NeueHealth, Inc. (NYSE: NEUE), a value-driven healthcare company, for approximately $1.3…
Anebulo Pharmaceuticals announces positive update and capital raise for Selonabant
Anebulo Pharmaceuticals announces positive update and capital raise for Selonabant Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB), a clinical-stage biopharmaceutical company focused on developing innovative treatments for acute cannabinoid-induced toxicities, has announced a positive regulatory update and the successful completion of a…
Refinancing plan unveiled by MultiPlan to strengthen its capital structure
Refinancing plan unveiled by MultiPlan to strengthen its capital structure MultiPlan Corporation (NYSE: MPLN), a prominent provider of technology and data solutions dedicated to cost management, quality improvement, and transparency in healthcare, has announced a comprehensive refinancing initiative. This refinancing…
Kidney disease: Proton Intelligence raises $6.95M for potassium monitoring trials
Kidney disease: Proton Intelligence raises $6.95M for potassium monitoring trials Proton Intelligence Inc., the developer of the innovative Continuous Potassium Monitoring (CKM™) platform, has successfully closed a $6.95 million USD Seed Financing round. The round was supported by investors including…
Approval Granted for SOLVD Health’s New York State Laboratory
Approval Granted for SOLVD Health’s New York State Laboratory SOLVD Health, a patient intelligence company specializing in advanced precision solutions to improve health outcomes, has received approval from the New York State Department of Health Clinical Laboratory Evaluation Program (CLEP)…